Bank of New York Mellon’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $59.3M | Buy |
|
|||||
|
2023
Q3 | $8.39M | Buy |
|
|||||
|
2023
Q2 | $6.62M | Buy |
|
|||||
|
2023
Q1 | $6.33M | Buy |
|
|||||
|
2022
Q4 | $7.66M | Sell |
|
|||||
|
2022
Q3 | $12.2M | Sell |
|
|||||
|
2022
Q2 | $43.1M | Buy |
|
|||||
|
2022
Q1 | $13M | Sell |
|
|||||
|
2021
Q4 | $24.7M | Buy |
|
|||||
|
2021
Q3 | $28.4M | Sell |
|
|||||
|
2021
Q2 | $29.5M | Buy |
|
|||||
|
2021
Q1 | $27.3M | Sell |
|
|||||
|
2020
Q4 | $42.5M | Buy |
|
|||||
|
2020
Q3 | $25.9M | Buy |
|
|||||
|
2020
Q2 | $17M | Buy |
|
|||||
|
2020
Q1 | $9.55M | Sell |
|
|||||
|
2019
Q4 | $16M | Buy |
|
|||||
|
2019
Q3 | $9.24M | Sell |
|
|||||
|
2019
Q2 | $13M | Buy |
|
|||||
|
2019
Q1 | $8.22M | Buy |
|
|||||
|
2018
Q4 | $4.1M | Sell |
|
|||||
|
2018
Q3 | $5.05M | Sell |
|
|||||
|
2018
Q2 | $5.43M | Buy |
|
|||||
|
2018
Q1 | $753K | Buy |
|
|||||
|
2017
Q4 | $323K | Buy |
|
|||||
|
2017
Q3 | $186K | Buy |
|
|||||
|
2017
Q2 | $54K | Sell |
|
|||||
|
2017
Q1 | $328K | Buy |
|
|||||
|
2016
Q4 | $244K | Sell |
|
|||||
|
2016
Q3 | $359K | Sell |
|
|||||
|
2016
Q2 | $332K | Sell |
|
|||||
|
2016
Q1 | $1.31M | Buy |
|
|||||
|
2015
Q4 | $1.77M | Sell |
|
|||||
|
2015
Q3 | $1.96M | Buy |
|
|||||
|
2015
Q2 | $1.11M | Buy |
|
|||||
|
2015
Q1 | $666K | Buy |
|
|||||
|
2014
Q4 | $382K | Sell |
|
|||||
|
2014
Q3 | $370K | Sell |
|
|||||
|
2014
Q2 | $424K | Buy |
|